vorasidenibum 40 mg ut vorasidenibi hemicitras hemihydricus, cellulosum microcristallinum, carmellosum natricum conexum, cellulosum microcristallinum silicificatum, natrii laurilsulfas, magnesii stearas, pellicule: hypromellosum, E 171, lactosum monohydricum 2.52 mg, macrogolum 4000, pro compresso obducto, encre: E 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto corresp. natrium max. 2.1 mg.
Packungsbestandteile
Coated tablets
Active Agent
Dose
Vorasidenibum
40 mg
Inactive agents
Dose
additional_information
(Nigrum)
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Cellulosum Microcristallinum Silicificatum
E 171
color.
E 172
encre
Hypromellosum
Lactose Monohydrate
2.52 mg
Macrogol
4000
Magnesii Stearas
Natrii Laurilsulfas
Pro Compresso Obducto
Propylenglycol
Source
Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
